Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TARO-BUPROPION XL SUN PHARMA CANADA INC Resolved 150MG Updated Report 2025-05-20 202125
TARO-BUPROPION XL SUN PHARMA CANADA INC Resolved 150MG Updated Report 2025-05-20 202122
TARO-APIXABAN SUN PHARMA CANADA INC Resolved 5MG Updated Report 2025-05-20 248909
TARO-APIXABAN SUN PHARMA CANADA INC Resolved 2.5MG Updated Report 2025-05-20 250041
BIO-ZOLMITRIPTAN BIOMED PHARMA Actual shortage 2.5MG Updated Report 2025-05-20 235779
BIO-FLUOXETINE BIOMED PHARMA Resolved 20MG Updated Report 2025-05-20 245164
MINT-ANASTROZOLE MINT PHARMACEUTICALS INC Actual shortage 1MG Updated Report 2025-05-20 248689
MINT-GLICLAZIDE MR MINT PHARMACEUTICALS INC Resolved 60MG Updated Report 2025-05-20 108289
BIO-FLUOXETINE BIOMED PHARMA Resolved 10MG Updated Report 2025-05-20 245167
MINT-LETROZOLE MINT PHARMACEUTICALS INC Actual shortage 2.5MG Updated Report 2025-05-20 217372

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED To be discontinued 15MG New Report 2025-05-15 257387
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED To be discontinued 30MG New Report 2025-05-15 257384
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED To be discontinued 25MG New Report 2025-05-15 257377
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED To be discontinued 20MG New Report 2025-05-15 257374
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED To be discontinued 5MG New Report 2025-05-15 257371